Electricity-free Infant Warmer for Newborn Thermoregulation in Rwanda
NCT ID: NCT03031431
Last Updated: 2020-01-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
130 participants
INTERVENTIONAL
2016-07-31
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Clinical Assessment of Low-cost Infant Incubator in Monitoring Temperature and Treating Hypothermia in Infants
NCT03965312
Study of the Need for Temperature Probe Covers for Newborn Babies on Radiant Warmers
NCT00312065
Efficacy of a Low-cost Warming Mattress Celsi Warmer for the Management of Hypothermic Newborns at Muhimbili National Hospital, Dar es Salaam, Tanzania
NCT05876884
Efficacy of Celsi Warmer for the Management of Hypothermic Newborns
NCT06000826
Blood Warming in Preterm Infants to Decrease Hypothermia
NCT05170633
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-Electric Infant Warmer
In line with current recommended practice, mothers will be encouraged to provide Kangaroo Mother Care (KMC) whenever possible. If an infant's temp is not rising by ½ degree C per hour with KMC alone, the infant warmer will be offered as an addition by the study team. If the mother is not available for KMC at any time, the infant will be warmed exclusively with the warmer. Bundling in clothes will only be used in addition to the warmer per carer preference. Temp measurement of the infant, warmer, and ambient air will be measured every 15 mins for the first hr, then hrly and as needed for the remainder of use or until warmer endpoint is reached (warmer temp below 36 degrees or phase-change material hardens \[soft, semisoft, or hardened\]).
Non-Electric Infant Warmer
Electric warmers are the standard of care in developed countries, but are extremely costly, complicated with risk of causing both hypo and hyperthermia with misuse, and often not feasible in settings without stable electricity. Through a multi-institutional collaboration, the investigators have developed an electricity-free infant warmer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-Electric Infant Warmer
Electric warmers are the standard of care in developed countries, but are extremely costly, complicated with risk of causing both hypo and hyperthermia with misuse, and often not feasible in settings without stable electricity. Through a multi-institutional collaboration, the investigators have developed an electricity-free infant warmer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. axillary temperature \< 36 degrees C and ≥35 degrees C 1a) If an electric warmer is available and the infant's temperature is \< 35 degrees C, then the infant would start by being warmed on the electric warmer until the infant's temperature reaches 36 degrees C, then can start non-electric infant warmer use
2. Infants at-risk for hypothermia (criteria: estimated post-menstrual age of \< 35 weeks or current body weight of \< 2.5 kg)
Exclusion Criteria
2. Mothers who are critically ill at the time of infant eligibility or deemed not medically stable by nursing staff to be approached for consent.
3. Any infant with a contraindication to Kangaroo Mother Care (medical instability) and electrical heating source available.
4. Any infant with initial temperature \< 35 degrees C and electrical heating source available.
5. Infants within the first hour of admission to neonatal unit or first hour of life in maternity.
6. Infants requiring phototherapy
7. Infants with significant skin condition
8. Infants with Hypoxic Ischemic Encephalopathy (HIE)
Stopping Criteria:
If an electric heating source is available, the infant will be taken off the study and warmed with an appropriate source of electric heat if the infant:
1. Is hypothermic and temperature decreases on any measurement
2. Is hypothermic and temperature does not begin to rise within 30 minutes
3. Is hypothermic and not heating at a rate of \> ½ degree C per hour until temperature is \>36.5 degrees C
4. Has a temperature that falls below 36 degrees C despite maximum exposure to the heat source
5. Is ever considered to be too severely ill by the medical team to be safely cared for in the non-electric infant warmer.
6. The warmer will be removed once its temperature drops below 36 degrees, and/or the phase change material begins to harden.
3 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Rwanda
OTHER_GOV
Rwandan Biomedical Counsel (RBC)
UNKNOWN
Harvard Medical School (HMS and HSDM)
OTHER
Institute for Transformative Technologies (ITT)
UNKNOWN
Brigham and Women's Hospital
OTHER
Partners in Health
OTHER
Boston Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne Hansen
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Hansen, MD
Role: PRINCIPAL_INVESTIGATOR
Boston Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr Evrard Nahimana
Rwinkwavu, , Rwanda
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-P00016205
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.